Vanta Bioscience Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Jun '25 Jun 16, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2018 - 2019
Market Capitalization	175	404	363	693	1,029	574	Upgrade
Market Cap Growth	15.89%	11.30%	-47.66%	-32.61%	79.12%	-51.14%	Upgrade
Enterprise Value	789	997	816	1,109	1,241	714	Upgrade
Last Close Price	27.79	64.00	57.50	109.85	163.00	91.00	Upgrade
PE Ratio	-	-	-	786.08	228.87	57.18	Upgrade
PS Ratio	3.82	4.16	5.78	6.92	10.24	4.06	Upgrade
PB Ratio	1.88	3.11	1.92	2.36	3.92	2.35	Upgrade
P/TBV Ratio	-	15.16	5.25	3.79	4.30	2.45	Upgrade
P/OCF Ratio	-	15.05	-	13.14	14.76	24.54	Upgrade
EV/Sales Ratio	17.20	10.25	13.01	11.07	12.35	5.05	Upgrade
EV/EBITDA Ratio	-	74.83	-	29.19	30.93	16.33	Upgrade
EV/EBIT Ratio	-	-	-	44.66	44.95	22.44	Upgrade
Debt / Equity Ratio	7.05	4.71	3.02	1.53	1.37	0.71	Upgrade
Debt / EBITDA Ratio	-	45.87	-	11.81	8.97	3.97	Upgrade
Asset Turnover	0.05	0.11	0.08	0.13	0.17	0.32	Upgrade
Inventory Turnover	-	0.11	0.14	0.10	0.08	0.12	Upgrade
Quick Ratio	0.11	0.14	0.12	0.36	0.55	0.36	Upgrade
Current Ratio	0.74	0.75	0.86	1.01	1.34	2.01	Upgrade
Return on Equity (ROE)	-73.02%	-53.95%	-43.27%	0.48%	1.77%	4.25%	Upgrade
Return on Assets (ROA)	-4.22%	-2.33%	-3.81%	2.05%	2.92%	4.54%	Upgrade
Return on Capital (ROIC)	-4.74%	-2.63%	-4.21%	2.27%	3.32%	5.08%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	3.70%	5.00%	8.20%	Upgrade
Earnings Yield	-21.94%	-5.73%	-17.86%	0.13%	0.44%	1.75%	Upgrade
FCF Yield	-24.31%	-1.78%	-80.77%	-17.16%	-14.79%	-8.72%	Upgrade
Buyback Yield / Dilution	0.06%	-	-	-	-	-	Upgrade

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.